← Back to Search

Patient Decision Aid for Opioid Use Disorder (PtDA-MAT Trial)

N/A
Recruiting
Led By Larissa Mooney, M.D.
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Opioid Use Disorder diagnosis and agreement to follow study procedures (including permission to share medical records and other administrative records)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

PtDA-MAT Trial Summary

This trial tests the effectiveness of a tool to help people with Opioid Use Disorder, by tracking their health and drug use outcomes over 24 months.

Eligible Conditions
  • Opioid Use Disorder

PtDA-MAT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

PtDA-MAT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Opioid Use at 3 months
Opioid Use at 6 months
Treatment Retention
Secondary outcome measures
Mortality
Substance Use
Treatment Adherence

PtDA-MAT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Patient Decision AidExperimental Treatment1 Intervention
Participating clinics (and their patients) will be randomly selected to implement the intervention, at which time their patients will receive Patient Decision Aid for Medication Assisted Treatment for opioid use disorder.
Group II: Prior to interventionActive Control1 Intervention
All participating clinics will start with a baseline period without the intervention. The clinics and their patients will remain in the no intervention condition until randomly selected to crossover to receive the intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Decision Aid
2020
N/A
~1480

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,521 Previous Clinical Trials
10,273,536 Total Patients Enrolled
Larissa Mooney, M.D.Principal InvestigatorUniversity of California, Los Angeles
2 Previous Clinical Trials
121 Total Patients Enrolled
Yih-Ing Hser, Ph.D.4.08 ReviewsPrincipal Investigator - University of California, Los Angeles
University of California, Los Angeles
3 Previous Clinical Trials
37,711 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1178 spots leftby Mar 2025